Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
Frontiers | Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device | Scientific Reports
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
trend in serum free light chain levels and kappa-lambda free light... | Download Scientific Diagram
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Anti-Hu Ig Lambda Light Chain PE - EXBIO Antibodies
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019 - Gupta - 2023 - Immunology & Cell Biology - Wiley Online Library
kappa Light Chain Antibody PE (ABIN1027676)
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma | Blood Cancer Journal
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Poliklonal Kappa Lambda Antikoru – IDA Yasam Teknolojileri
Isolation of Circulating Plasma Cells in Multiple Myeloma Using CD138 Antibody-Based Capture in a Microfluidic Device | Scientific Reports
Lambda-IgLC Antibody (ABIN775718)
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma